Anticoagulation practice patterns in COVID‐19: A global survey
Rachel Rosovsky(Harvard University), Lisa Baumann Kreuziger(Medical College of Wisconsin), Sandeep K. Rajan(University of Tennessee Health Science Center), Menno V. Huisman(Leiden University Medical Center), Beverley J. Hunt, Tzu‐Fei Wang(The Ohio State University Wexner Medical Center), Kristen M. Sanfilippo(St. Louis VA Medical Center), Karlyn A. Martin(University of North Carolina at Chapel Hill), Fionnuala Ní Áinle(University College Dublin), Surbhi Shah(Optum (United States)), Susan R. Kahn(McGill University), Barry Kevane(University College Dublin), Agnes Lee(University of British Columbia), Claire McLintock(Auckland City Hospital)
Cited by 45
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|861
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
|New England Journal of Medicine|2017|851
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
|European Journal of Vascular and Endovascular Surgery|2020|709